RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Titan Pharmaceuticals Stock

Titan Pharmaceuticals Debt 2025

Titan Pharmaceuticals Debt

-6.26 USD

Ticker

TTNP

ISIN

US8883147055

WKN

A2QJPT

In 2025, Titan Pharmaceuticals's total debt was -6.26 USD, a 113.14% change from the -2.94 USD total debt recorded in the previous year.

Titan Pharmaceuticals Aktienanalyse

What does Titan Pharmaceuticals do?

Titan Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Titan Pharmaceuticals's Debt Structure

Titan Pharmaceuticals's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Titan Pharmaceuticals's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Titan Pharmaceuticals’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Titan Pharmaceuticals’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Titan Pharmaceuticals stock

What is the debt of Titan Pharmaceuticals this year?

Titan Pharmaceuticals has a debt level of -6.26 USD this year.

What was the debt of Titan Pharmaceuticals compared to the previous year?

The debt of Titan Pharmaceuticals has increased by 113.14% compared to the previous year increased.

What are the consequences of high debt for investors in Titan Pharmaceuticals?

High debt can pose a risk for investors of Titan Pharmaceuticals, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Titan Pharmaceuticals?

Low debt means that Titan Pharmaceuticals has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Titan Pharmaceuticals affect the company?

An increase in debt of Titan Pharmaceuticals can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Titan Pharmaceuticals affect the company?

A reduction in debt of Titan Pharmaceuticals can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Titan Pharmaceuticals?

Some factors that can influence the debt of Titan Pharmaceuticals include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Titan Pharmaceuticals so important for investors?

The debts of Titan Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Titan Pharmaceuticals take to change the debt?

To change the debt, Titan Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Titan Pharmaceuticals pay?

Over the past 12 months, Titan Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Titan Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Titan Pharmaceuticals?

The current dividend yield of Titan Pharmaceuticals is .

When does Titan Pharmaceuticals pay dividends?

Titan Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Titan Pharmaceuticals?

Titan Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Titan Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Titan Pharmaceuticals located?

Titan Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Titan Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Titan Pharmaceuticals from 3/9/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/9/2025.

When did Titan Pharmaceuticals pay the last dividend?

The last dividend was paid out on 3/9/2025.

What was the dividend of Titan Pharmaceuticals in the year 2024?

In the year 2024, Titan Pharmaceuticals distributed 0 USD as dividends.

In which currency does Titan Pharmaceuticals pay out the dividend?

The dividends of Titan Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Titan Pharmaceuticals

Our stock analysis for Titan Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Titan Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.